Using Sujok Therapy to Improve Comfort and Reduce Pain and Anxiety in Cancer Patients with Port Catheters
The Effect of Sujok Therapy on Patient Comfort, Pain Intensity, and Anxiety Level in Cancer Patients With Port Catheter Placement: A Randomized, Placebo and Controlled Study
This study is testing whether Sujok therapy can help cancer patients with port catheters feel less pain and anxiety during their chemotherapy treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Firat University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Elazığ, Center) |
| Trial ID | NCT06430177 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Sujok therapy on cancer patients who are undergoing chemotherapy and have a port catheter placed for treatment. The approach focuses on non-pharmacological methods to alleviate pain, anxiety, and improve overall patient comfort during invasive procedures associated with port catheter management. Participants will receive Sujok therapy to assess its impact on their pain intensity and anxiety levels. The study aims to provide insights into alternative therapeutic options for managing discomfort in cancer care.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who have been diagnosed with cancer and are scheduled to receive chemotherapy with port catheter placement.
Not a fit: Patients with chronic pain or anxiety disorders, or those using analgesics or anxiolytics, may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance the comfort and emotional well-being of cancer patients undergoing chemotherapy.
How similar studies have performed: While the use of Sujok therapy is less common, similar non-pharmacological approaches have shown promise in managing pain and anxiety in other patient populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being over 18 years of age * Ability to communicate adequately * Being diagnosed with cancer * Will receive chemotherapy treatment * Port catheter placement will be performed * Suitable for Implantable Port Catheter Placement Exclusion Criteria: * Loss of sensation in the hands, amputation, injury, etc. that would prevent practice. to be * Patients with chronic pain or anxiety disorders, using any analgesics or anxiolytics
Where this trial is running
Elazığ, Center
- Fırat university — Elazığ, Center, Turkey (Recruiting)
Study contacts
- Study coordinator: Gülcan Bahçecioğlu Turan
- Email: glcnbah@hotmail.com
- Phone: 05065576086
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.